FHTX CIK: 1822462

Foghorn Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.3
FY22:
194
FY23:
−118
FY24:
−100
FY25:
−86.1
Change from FY21 to FY25
millions USD
FY21:
36.2
FY22:
−244
FY23:
144
FY24:
−29.9
FY25:
112
Change from FY21 to FY25
millions USD
FY21:
22.4
FY22:
1.76
FY23:
1.78
FY24:
105
FY25:
1.02
(positive)
Change from FY21 to FY25
millions USD
FY21:
−53.6
FY22:
192
FY23:
−119
FY24:
−101
FY25:
−86.1

All amounts in millions USD Data source:SEC EDGAR